0001209191-17-019697.txt : 20170309 0001209191-17-019697.hdr.sgml : 20170309 20170309180310 ACCESSION NUMBER: 0001209191-17-019697 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170307 FILED AS OF DATE: 20170309 DATE AS OF CHANGE: 20170309 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NUVASIVE INC CENTRAL INDEX KEY: 0001142596 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 330768598 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7475 LUSK BLVD. CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 909-1800 MAIL ADDRESS: STREET 1: 7475 LUSK BLVD. CITY: SAN DIEGO STATE: CA ZIP: 92121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hannon Jason CENTRAL INDEX KEY: 0001330401 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50744 FILM NUMBER: 17679711 MAIL ADDRESS: STREET 1: 7475 LUSK BLVD. CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-03-07 0 0001142596 NUVASIVE INC NUVA 0001330401 Hannon Jason 7475 LUSK BLVD SAN DIEGO CA 92121 0 1 0 0 President and COO Common Stock 2017-03-07 4 M 0 97375 34.82 A 142336 D Common Stock 2017-03-07 4 F 0 72535 74.63 D 69801 D Common Stock 2017-03-08 4 S 0 24340 74.21 D 45461 D Common Stock 2017-03-08 4 S 0 500 74.80 D 44961 D Employee Stock Option (Right to Buy) 34.82 2017-03-07 4 M 0 97375 0.00 D 2019-01-02 Common Stock 97375 0 D Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards. Payment of exercise price and tax liability by Issuer's withholding of shares incident to the respective option exercise. Sales effected pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person, which is intended to comply with Rule 10b5-1. Weighted average sales price from sales transactions ranging from $73.71 to $74.70. Upon request by the Commission staff or a security holder of the Issuer, either the Issuer or the Reporting Person will undertake to provide full information regarding the number of shares sold at each separate price. Weighted average sales price from sales transactions ranging from $74.74 to $74.91. Upon request by the Commission staff or a security holder of the Issuer, either the Issuer or the Reporting Person will undertake to provide full information regarding the number of shares sold at each separate price. The option, representing a right to purchase a total of 97,375 shares, was granted on January 2, 2009 and is fully vested. /s/ Nathaniel B. Sisitsky, Attorney-in-Fact for Jason M. Hannon 2017-03-09